The MSH2 gene is the most commonly mutated LS gene in MTS, and individuals with LS carrying MLH1 or MSH2 mutations are significantly more likely to develop skin cancer than those with MSH6 or PMS2 mutations [59, 60]. This evidence concerns the gene MLH1 and skin neoplasm.